QI
UTHR icon

Qtron Investments’s United Therapeutics UTHR Stock Holding History

Qtron Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519K Sell
958
-195
-17% -$110K 0.07% 321
2026
Q1 		$684K Hold
1,153
– – 0.09% 270
2025
Q4 		$562K Hold
1,153
– – 0.07% 299
2025
Q3 		$483K Sell
1,153
-1,278
-53% -$430K 0.06% 338
2025
Q2 		$699K Buy
2,431
+677
+39% +$202K 0.09% 269
2025
Q1 		$541K Buy
1,754
+997
+132% +$342K 0.08% 286
2024
Q4 		$267K Hold
757
– – 0.04% 382
2024
Q3 		$271K Buy
+757
New +$256K 0.04% 385
2023
Q2 		– Sell
-1,299
Closed -$291K – 442
2023
Q1 		$291K Buy
+1,299
New +$320K 0.06% 354

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Qtron Investments's UTHR Position: Q2 2026 in Review

Qtron Investments reduced its United Therapeutics (UTHR) stake by 17% in Q2 2026, selling an estimated $110K and leaving 958 shares worth $519K. The position accounts for 0.07% of the portfolio, ranked #321.

Qtron Investments first reported a position in UTHR in Q1 2023 and has held it in 9 quarters since. The position peaked at $699K in Q2 2025. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Qtron Investments held 958 shares of United Therapeutics worth $519K as of Q2 2026.
  • Qtron Investments sold 195 United Therapeutics shares in Q2 2026, an estimated $110K.
  • United Therapeutics made up 0.07% of Qtron Investments's portfolio in Q2 2026, its #321 holding.
  • Qtron Investments first reported a position in United Therapeutics in Q1 2023 and has held it in 9 quarters since.
  • Qtron Investments's United Therapeutics position peaked at $699K in Q2 2025.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.